Salvato in:
| Autore principale: | Moesgaard, Laust |
|---|---|
| Natura: | Recurso digital |
| Lingua: | |
| Pubblicazione: |
Zenodo
2025
|
| Accesso online: | https://doi.org/10.5281/zenodo.17580832 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
Documenti analoghi
Discovery of Novel FtsZ Inhibitors With Antimicrobial Activity by Virtual Screening and In Vitro Biological Evaluation
di: Aoqi Luo, et al.
Pubblicazione: (2025)
di: Aoqi Luo, et al.
Pubblicazione: (2025)
Discovery of Novel HPK1 Inhibitors via High‐Throughput Virtual Screening, Biological Evaluation, and Molecular Dynamics Simulation
di: Xinglong Chi, et al.
Pubblicazione: (2026)
di: Xinglong Chi, et al.
Pubblicazione: (2026)
Discovery of Potential GPRC5D Inhibitors through Virtual Screening and Molecular Dynamics Simulations
di: Xi Chen, et al.
Pubblicazione: (2025)
di: Xi Chen, et al.
Pubblicazione: (2025)
Integration of Consensus‐Based Pharmacophore Mapping and Molecular Docking in Sequential Virtual Screening: Toward the Discovery of Novel PI3Kγ Inhibitors
di: Xiaolian Yu, et al.
Pubblicazione: (2024)
di: Xiaolian Yu, et al.
Pubblicazione: (2024)
Discovery of 1‐(arylacetyl)‐2‐phenyl‐pyrrolidine Derivatives as Novel POLθ‐pol Inhibitors via Structure‐Based Virtual Screening and Fragment Fusion
di: Wenlin Fan, et al.
Pubblicazione: (2025)
di: Wenlin Fan, et al.
Pubblicazione: (2025)
Structure‐Based Pharmacophore Modeling, Virtual Screening, and Molecular Dynamics Simulation for the Discovery of Novel BRAF(V600E) Inhibitors in Melanoma Cancer
di: Salma Boulahia, et al.
Pubblicazione: (2026)
di: Salma Boulahia, et al.
Pubblicazione: (2026)
Unveiling Novel Arginase Inhibitors for Cutaneous Leishmaniasis Using Drug Repurposing and Virtual Screening Approaches
di: Eduarda Moreira Barreto, et al.
Pubblicazione: (2025)
di: Eduarda Moreira Barreto, et al.
Pubblicazione: (2025)
Virtual Screening and Biological Evaluation of Natural Products as Novel VPS34 Inhibitors that Modulate Autophagy
di: Xiaowen Feng, et al.
Pubblicazione: (2024)
di: Xiaowen Feng, et al.
Pubblicazione: (2024)
Discovery of Tetrahydropyrrolo[3,4‐c]pyrrole‐1,3‐dione Derivatives as Novel RIPK1 Inhibitors via Pharmacophore‐Based Virtual Screening
di: Xin Zeng, et al.
Pubblicazione: (2026)
di: Xin Zeng, et al.
Pubblicazione: (2026)
Integration of Multicomplex‐Based Pharmacophore Modeling and Molecular Docking in Machine Learning‐Based Virtual Screening: Toward the Discovery of Novel PI3K Inhibitors
di: Shuo Qiu, et al.
Pubblicazione: (2024)
di: Shuo Qiu, et al.
Pubblicazione: (2024)
Accelerating Discovery: Rapid Literature Screening with LLMs
di: Matalonga, Santiago, et al.
Pubblicazione: (2025)
di: Matalonga, Santiago, et al.
Pubblicazione: (2025)
Structure‐Based Virtual Screening and Biological Characterization of Novel BACE‐1 and Amyloid‐β Aggregation Inhibitors
di: Ankita Sharma, et al.
Pubblicazione: (2024)
di: Ankita Sharma, et al.
Pubblicazione: (2024)
Discovery of PARP‐1 Inhibitors for Triple‐Negative Breast Cancer via Structure‐Based Virtual High‐Throughput Screening
di: Shahrazad Polk, et al.
Pubblicazione: (2025)
di: Shahrazad Polk, et al.
Pubblicazione: (2025)
Parallelized Tools for the Preparation and Curation of Large Libraries for Virtual Screening
di: Andreas Vitalis, et al.
Pubblicazione: (2025)
di: Andreas Vitalis, et al.
Pubblicazione: (2025)
Discovery of Small‐Molecules as Potential GSK‐3β Inhibitors for the Treatment of Alzheimer's Disease Using Pharmacophore‐Based Virtual Screening
di: Kailash Jangid, et al.
Pubblicazione: (2024)
di: Kailash Jangid, et al.
Pubblicazione: (2024)
Discovery of Chemically Distinct DprE1 Inhibitors With Sub‐Nanomolar Predicted Potency Via Virtual Screening and Molecular Dynamics
di: Fady H. Fayek, et al.
Pubblicazione: (2026)
di: Fady H. Fayek, et al.
Pubblicazione: (2026)
Discovery of Antivirulence ClpP Inhibitors by Self‐Resistance Gene‐Guided Mining Coupled with Dual Functional Screening
di: Yongchao Wang, et al.
Pubblicazione: (2025)
di: Yongchao Wang, et al.
Pubblicazione: (2025)
Discovery of Antivirulence ClpP Inhibitors by Self‐Resistance Gene‐Guided Mining Coupled with Dual Functional Screening
di: Yongchao Wang, et al.
Pubblicazione: (2025)
di: Yongchao Wang, et al.
Pubblicazione: (2025)
Discovery of a Novel and Potent Kir4.1 Inhibitor as a Safe and Rapid‐Onset Antidepressant Agent in Mice
di: Sisi Wang, et al.
Pubblicazione: (2025)
di: Sisi Wang, et al.
Pubblicazione: (2025)
Unveiling the Boson Peaks in Amorphous Phase-Change Materials
di: Moesgaard, Jens, et al.
Pubblicazione: (2024)
di: Moesgaard, Jens, et al.
Pubblicazione: (2024)
Phytochemical‐Based Drug Discovery for Breast Cancer: Combining Virtual Screening and Molecular Dynamics to Identify Novel Therapeutics
di: Trupti Pratik Durgawale, et al.
Pubblicazione: (2025)
di: Trupti Pratik Durgawale, et al.
Pubblicazione: (2025)
Construction of Virtual Compound Library and Screening of Acetylcholinesterase Inhibitor for the Medicinal Chemistry Laboratory
di: Jie Yang, et al.
Pubblicazione: (2024)
di: Jie Yang, et al.
Pubblicazione: (2024)
A Novel Triose Phosphate Isomerase Inhibitor With Dual Trypanosomicidal Activity was Identified Using Artificial Intelligence‐Based Virtual Screening
di: Elena Aguilera, et al.
Pubblicazione: (2026)
di: Elena Aguilera, et al.
Pubblicazione: (2026)
Inhibition of P‐glycoprotein using photoimmunotherapy in peritoneal metastasis mouse model
di: Kaitlyn A. Moore, et al.
Pubblicazione: (2026)
di: Kaitlyn A. Moore, et al.
Pubblicazione: (2026)
Discovery and in vitro Evaluation of Novel Serotonin 5‐HT2A Receptor Ligands Identified Through Virtual Screening
di: Agata Zięba, et al.
Pubblicazione: (2024)
di: Agata Zięba, et al.
Pubblicazione: (2024)
Discovery of a Novel Cyclopeptide as Tyrosinase Inhibitor for Skin Lightening
di: Huailong Chang, et al.
Pubblicazione: (2025)
di: Huailong Chang, et al.
Pubblicazione: (2025)
Phenomics‐Based Discovery of Novel Orthosteric Choline Kinase Inhibitors
di: Ludwig G. Bauer, et al.
Pubblicazione: (2025)
di: Ludwig G. Bauer, et al.
Pubblicazione: (2025)
Development of an Integrated Computational Pipeline for PARP‐1 Inhibitor Screening Using Hybrid Virtual Screening and Molecular Dynamics Simulations
di: Guan Wang, et al.
Pubblicazione: (2025)
di: Guan Wang, et al.
Pubblicazione: (2025)
Screening of Novel Hydroxamic Acid Derivatives as ASM Inhibitors for the Treatment of Depression
di: Shankar Gupta, et al.
Pubblicazione: (2024)
di: Shankar Gupta, et al.
Pubblicazione: (2024)
Nanoengineered photosensitizers for photodynamic priming to overcome P‐glycoprotein‐mediated multidrug resistance
di: Idrisa Rahman, et al.
Pubblicazione: (2025)
di: Idrisa Rahman, et al.
Pubblicazione: (2025)
Discovery of Na1.7 Inhibitors through the Screening of Marine Natural Product Extracts.
di: Adewole, Adetola H, et al.
Pubblicazione: (2025)
di: Adewole, Adetola H, et al.
Pubblicazione: (2025)
Identification and Biological Evaluation of a Novel CLK4 Inhibitor Targeting Alternative Splicing in Pancreatic Cancer Using Structure‐Based Virtual Screening
di: Chun‐Lin Yang, et al.
Pubblicazione: (2025)
di: Chun‐Lin Yang, et al.
Pubblicazione: (2025)
Discovery of Azole‐Based COX‐2 Inhibitors Targeting Neuroinflammation in Alzheimer's Disease Via Integrated QSAR‐Based Virtual Screening, Molecular Docking, and Molecular Dynamics
di: Sanjana Das, et al.
Pubblicazione: (2026)
di: Sanjana Das, et al.
Pubblicazione: (2026)
Identification of Potent Leucine‐Rich Repeat Kinase 2 Inhibitors by Virtual Screening and Biological Evaluation
di: Hualiang Shen, et al.
Pubblicazione: (2025)
di: Hualiang Shen, et al.
Pubblicazione: (2025)
Screening Novel Furoxan Derivatives as Potential Inhibitors Targeting Thioredoxin Glutathione Reductase of .
di: Han, Yanhui, et al.
Pubblicazione: (2025)
di: Han, Yanhui, et al.
Pubblicazione: (2025)
P‐glycoprotein modulates the fluidity gradient of the plasma membrane of multidrug resistant CHO cells
di: Roger Busche, et al.
Pubblicazione: (2025)
di: Roger Busche, et al.
Pubblicazione: (2025)
Novel ectopic expression of zona pellucida 3 glycoprotein in lung cancer promotes tumor growth
di: Kamila Pulawska‐Moon, et al.
Pubblicazione: (2024)
di: Kamila Pulawska‐Moon, et al.
Pubblicazione: (2024)
Nanomole Scale Screening of Fluorescent RNA‐Methyltransferase Probes Enables the Discovery of METTL1 Inhibitors
di: J. Laurenz Meidner, et al.
Pubblicazione: (2024)
di: J. Laurenz Meidner, et al.
Pubblicazione: (2024)
ChemHGNN: A Hierarchical Hypergraph Neural Network for Reaction Virtual Screening and Discovery
di: Huang, Xiaobao, et al.
Pubblicazione: (2025)
di: Huang, Xiaobao, et al.
Pubblicazione: (2025)
Uncovering Potential Inhibitors of Mycobacterium Tuberculosis Eis Protein: Insights from Virtual Screening and Molecular Dynamics
di: R. Thilagavathi, et al.
Pubblicazione: (2025)
di: R. Thilagavathi, et al.
Pubblicazione: (2025)
Documenti analoghi
-
Discovery of Novel FtsZ Inhibitors With Antimicrobial Activity by Virtual Screening and In Vitro Biological Evaluation
di: Aoqi Luo, et al.
Pubblicazione: (2025) -
Discovery of Novel HPK1 Inhibitors via High‐Throughput Virtual Screening, Biological Evaluation, and Molecular Dynamics Simulation
di: Xinglong Chi, et al.
Pubblicazione: (2026) -
Discovery of Potential GPRC5D Inhibitors through Virtual Screening and Molecular Dynamics Simulations
di: Xi Chen, et al.
Pubblicazione: (2025) -
Integration of Consensus‐Based Pharmacophore Mapping and Molecular Docking in Sequential Virtual Screening: Toward the Discovery of Novel PI3Kγ Inhibitors
di: Xiaolian Yu, et al.
Pubblicazione: (2024) -
Discovery of 1‐(arylacetyl)‐2‐phenyl‐pyrrolidine Derivatives as Novel POLθ‐pol Inhibitors via Structure‐Based Virtual Screening and Fragment Fusion
di: Wenlin Fan, et al.
Pubblicazione: (2025)